Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid
Authors:
- Mohsen Karami FathMFMohsen Karami Fath
- Jalil AzamiJAJalil Azami
- Niloofar JaafariNJNiloofar Jaafari
- Mahsa Akbari OryaniMOMahsa Akbari Oryani
- Nafiseh JafariNJNafiseh Jafari
- Ali AzargoonjahromiAAAli Azargoonjahromi
- Mohsen Nabi-AfjadiMNMohsen Nabi-Afjadi
- Zahra PayandehZPZahra Payandeh
- Hamidreza ZalpoorHZHamidreza Zalpoor
- Dariush ShanehbandiDSDariush Shanehbandi
Open Access
- 5 September 2022
- journal article
- review article
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 27 (1) , 1-28
Abstract
Exosomes, known as a type of extracellular vesicles (EVs), are lipid particles comprising heterogeneous contents such as nucleic acids, proteins, and DNA. These bi-layered particles are naturally released into the extracellular periphery by a variety of cells such as neoplastic cells. Given that exosomes have unique properties, they can be used as vectors and carriers of biological and medicinal particles like drugs for delivering to the desired areas. The proteins and RNAs being encompassed by the circulating exosomes in B-cell malignancies are deemed as the promising sources for diagnostic and prognostic biomarkers, as well as therapeutic agents. Exosomes can also provide a “snapshot” view of the tumor and metastatic landscape at any particular time. Further, clinical research has shown that exosomes are produced by immune cells such as dendritic cells can stimulate the immune system, so these exosomes can be used in antitumor vaccines. Despite the great potential of exosomes in the fields of diagnostic and treatment, further studies are in need for these purposes to reach a convergence notion. This review highlights the applications of exosomes in multiple immune-related diseases, including chronic lymphocytic leukemia, multiple sclerosis, and arthritis rheumatoid, as well as explaining sundry aspects of exosome therapy and the function of exosomes in diagnosing diseases.Keywords
This publication has 205 references indexed in Scilit:
- The ESCRT machineryCurrent Biology, 2012
- Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashionAngiogenesis, 2011
- Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cellsCell Research, 2011
- Increasing vaccine potency through exosome antigen targetingVaccine, 2011
- Altered expression of microRNA‐203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activationArthritis & Rheumatism, 2010
- Altered miRNA expression in T regulatory cells in course of multiple sclerosisJournal of Neuroimmunology, 2010
- Biologic and clinical significance of molecular profiling in Chronic Lymphocytic LeukemiaBlood Reviews, 2010
- Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritisArthritis & Rheumatism, 2009
- Therapeutic effect of exosomes from indoleamine 2,3‐dioxygenase–positive dendritic cells in collagen‐induced arthritis and delayed‐type hypersensitivity disease modelsArthritis & Rheumatism, 2009
- Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 ProteinImmunity, 2009